Annual General Meeting 2018
The Annual General Meeting in Oncopeptides AB will be held on Thursday May 17, 2018, at 15.00 CET, at Tändstickspalatset, Västra Trädgårdsgatan 15, Stockholm, Sweden.
Upcoming events
Webcast - CHMP issues a positive opinion recommending full approval of Oncopeptides Pepaxti in EU
11:00 CET
June 23, 2022, the European Medicines Agency´s (EMA) Committee for Medicinal Products for Human Use (CHMP), has unanimously adopted a positive opinion recommending a full marketing authorization approval (MAA) of Pepaxti® (melphalan flufenamide, also called melflufen) in EU.
Annual General Meeting 2022
The Annual General Meeting in Oncopeptides AB (publ) will be held on Tuesday June 28, 2022, (changed from May 19, 2022) in Stockholm, Sweden. Due to the extraordinary situation resulting from the covid-19 pandemic, Oncopeptides’ Annual General Meeting will be carried out through advance voting (postal voting) pursuant to temporary legislation. No meeting with the possibility to attend in person or to be represented by a proxy will take place. Hence, the Annual General Meeting will be held without physical presence.